Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Putra Mandiri Jembar Tbk. (PMJS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp111 (market cap 1.53T, 865.6K 24h volume). The key difference: Putra Mandiri Jembar Tbk. is far larger — about 8.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Putra Mandiri Jembar Tbk. is more actively traded (865.6K versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PMJS | |
|---|---|---|
Market Cap | 172.82B | 1.53T |
Volume | 592.2K | 865.6K |
Lot | 5.92K | 8.66K |
Turnover | 147.05M | 98M |
Average Price | 248.31 | 113.22 |
Value | 147.05M | 98M |
Indicative Equilibrium Price | 254 | 111 |
Indicative Equilibrium Volume | 10 | 130 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Putra Mandiri Jembar Tbk.
PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →
